Prophylactic Stabilization for Bone Metastases, Myeloma, or Lymphoma: Do We Need to Protect the Entire Bone?
The current operative standard of care for disseminated malignant bone disease suggests stabilizing the entire bone to avoid the need for subsequent operative intervention but risks of doing so include complications related to embolic phenomena.
We questioned whether progression and reoperation occur with enough frequency to justify additional risks of longer intramedullary devices.
A retrospective chart review was done for 96 patients with metastases, myeloma, or lymphoma who had undergone stabilization or arthroplasty of impending or actual femoral or humeral pathologic fractures using an approach favoring intramedullary fixation devices and long-stem arthroplasty. Incidence of progressive bone disease, reoperation, and complications associated with fixation and arthroplasty devices in instrumented femurs or humeri was determined.
At minimum 0 months followup (mean, 11 months; range, 0–72 months), 80% of patients had died. Eleven of 96 patients (12%) experienced local bony disease progression; eight had local progression at the original site, two had progression at originally recognized discretely separate lesions, and one had a new lesion develop in the bone that originally was surgically treated. Six subjects (6.3%) required repeat operative intervention for symptomatic failure. Twelve (12.5%) patients experienced physiologic nonfatal complications potentially attributable to embolic phenomena from long intramedullary implants.
Because most patients in this series were treated with the intent to protect the bone with long intramedullary implants when possible, the reoperation rate may be lower than if the entire bone had not been protected. However, the low incidence of disease progression apart from originally identified lesions (one of 96) was considerably lower than the physiologic complication rate (12 of 96) potentially attributable to long intramedullary implants.
Level of Evidence
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Ampil FL, Sadasivan KK. Prophylactic and therapeutic fixation of weight-bearing long bones with metastatic cancer. South Med J. 2001;94:394–396.
- Berman AT, Hermantin FU, Horowitz SM. Metastatic disease of the hip: evaluation and treatment. J Am Acad Orthop Surg. 1997;5:79–86.
- Bickels J, Dadia S, Lidar Z. Surgical management of metastatic bone disease. J Bone Joint Surg Am. 2009;91:1503–1516. CrossRef
- Cheng EY. Prospective quality of life research in bony metastatic disease. Clin Orthop Relat Res. 2003;415(suppl):S289–297. CrossRef
- Damron TA. Metastatic disease. In: Damron TA, ed. Orthopaedic Essentials: Oncology and Basic Science. Baltimore, MD, USA: Lippincott Williams & Wilkins; 2007.
- Damron TA, Palomino K, Roach S. Long Gamma nail stabilization of pathologic and impending pathologic femur fractures. The University of Pennsylvania Orthopaedic Journal. 1999;12:13–20.
- Damron TA, Rock MG, Choudhury SN, Grabowski JJ, An KN. Biomechanical analysis of prophylactic fixation for middle third humeral impending pathologic fractures. Clin Orthop Relat Res. 1999;363:240–248. CrossRef
- Damron TA, Sim FH, Shives TC, An KN, Rock MG, Pritchard DJ. Intercalary spacers in the treatment of segmentally destructive diaphyseal humeral lesions in disseminated malignancies. Clin Orthop Relat Res. 1996;324:233–243. CrossRef
- Dijkstra S, Stapert J, Boxma H, Wiggers T. Treatment of pathological fractures of the humeral shaft due to bone metastases: a comparison of intramedullary locking nail and plate osteosynthesis with adjunctive bone cement. Eur J Surg Oncol. 1996;22:621–626. CrossRef
- Dijstra S, Wiggers T, van Geel BN, Boxma H. Impending and actual pathological fractures in patients with bone metastases of the long bones: a retrospective study of 233 surgically treated fractures. Eur J Surg. 1994;160:535–542.
- Frassica FJ, Frassica DA. Evaluation and treatment of metastases to the humerus. Clin Orthop Relat Res. 2003;415(suppl):S212–218. CrossRef
- Frassica FJ, Frassica DA. Metastatic bone disease of the humerus. J Am Acad Orthop Surg. 2003;11:282–288.
- Gibbons CE, Pope SJ, Murphy JP, Hall AJ. Femoral metastatic fractures treated with intramedullary nailing. Int Orthop. 2000;24:101–103. CrossRef
- Habermann ET, Lopez RA. Metastatic disease of bone and treatment of pathological fractures. Orthop Clin North Am. 1989;20:469–486.
- Haentjens P, Casteleyn PP, Opdecam P. Evaluation of impending fractures and indications for prophylactic fixation of metastases in long bones: review of the literature. Acta Orthop Belg. 1993;59(suppl 1):6–11.
- Harrington KD. Orthopedic surgical management of skeletal complications of malignancy. Cancer. 1997;80(8 suppl):1614–1627. CrossRef
- Healey JH, Brown HK. Complications of bone metastases: surgical management. Cancer. 2000;88(12 suppl):2940–2951. CrossRef
- Herrenbruck T, Erickson EW, Damron TA, Heiner J. Adverse clinical events during cemented long-stem femoral arthroplasty. Clin Orthop Relat Res. 2002;395:154–163. CrossRef
- Król R, Radomski S. Fixation of pathological fractures and impending long bone fractures in the course of neoplastic disease with the use of polymethylmethacrylate with added methotrexate. Ortop Traumatol Rehabil. 2003;5:319–326.
- Leddy LR. Rationale for reduced pressure reaming when stabilizing actual or impending pathological femoral fractures: a review of the literature. Injury. 2010;41(suppl 2):S48–50. CrossRef
- Les KA, Nicholas RW, Rougraff B, Wurtz D, Vogelzang NJ, Simon MA, Peabody TD. Local progression after operative treatment of metastatic kidney cancer. Clin Orthop Relat Res. 2001;390:206–211. CrossRef
- Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am. 2007;89:1794–1801. CrossRef
- Nilsson J, Gustafson P. Surgery for metastatic lesions of the femur: good outcome after 245 operations in 216 patients. Injury. 2008;39:404–410. CrossRef
- Papagelopoulos PJ, Savvidou OD, Galanis EC, Mavrogenis AF, Jacofsky DJ, Frassica FJ, Sim FH. Advances and challenges in diagnosis and management of skeletal metastases. Orthopedics. 2006;29:609–620; quiz 621–622.
- Patterson BM, Healey JH, Cornell CN, Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component. J Bone Joint Surg Am. 1991;73:271–277.
- Pitto RP, Koessler M, Kuehle JW. Comparison of fixation of the femoral component without cement and fixation with use of a bone-vacuum cementing technique for the prevention of fat embolism during total hip arthroplasty: a prospective randomized clinical trial. J Bone Joint Surg Am. 1999;81:831–843.
- Pritchard DJ. Metastatic bone disease: pathologic fractures of the humerus. Orthopedics. 1992;15:557–562.
- Randall RL, Aoki SK, Olson PR, Bott SI. Complications of cemented long-stem hip arthroplasties in metastatic bone disease. Clin Orthop Relat Res. 2006;443:287–295. CrossRef
- Randall RL, Hoang BH. Musculoskeletal oncology. In: Skinner HB, ed. Current Diagnosis and Treatment in Orthopedics. 4th ed. New York, NY, USA: McGraw-Hill; 2006: 298–380.
- Rock MG. Metastatic lesions of the humerus and the upper extremity. Instr Course Lect. 1992;41:329–333.
- Sharma H, Bhagat S, McCaul J, Macdonald D, Rana B, Naik M. Intramedullary nailing for pathological femoral fractures. J Orthop Surg (Hong Kong). 2007;15:291–294.
- Swanson KC, Pritchard DJ, Sim FH. Surgical treatment of metastatic disease of the femur. J Am Acad Orthop Surg. 2000;8:56–65.
- Vandeweyer E, Gebhart M. Treatment of humeral pathological fractures by internal fixation and methylmetacrylate injection. Eur J Surg Oncol. 1997;23:238–242. CrossRef
- Ward WG, Spang J, Howe D. Metastatic disease of the femur: surgical management. Orthop Clin North Am. 2000;31:633–645. CrossRef
- Weber KL, Lewis VO, Randall RL, Lee AK, Springfield D. An approach to the management of the patient with metastatic bone disease. Instr Course Lect. 2004;53:663–676.
- Wedin R. Surgical treatment for pathologic fracture. Acta Orthop Scand Suppl. 2001;72:1–29.
- Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg Br. 2005;87:1653–1657.
- Wedin R, Bauer HC, Wersäll P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop Relat Res. 1999;358:128–139. CrossRef
- Weikert DR, Schwartz HS. Intramedullary nailing for impending pathological subtrochanteric fractures. J Bone Joint Surg Br. 1991;73:668–670.
- Prophylactic Stabilization for Bone Metastases, Myeloma, or Lymphoma: Do We Need to Protect the Entire Bone?
Clinical Orthopaedics and Related Research®
Volume 471, Issue 3 , pp 706-714
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Orthopedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- 2. Upstate Orthopedic Surgery, Upstate Bone and Joint Center, Upstate Medical University, 6620 Fly Road, East Syracuse, NY, 13057, USA